Effectiveness of two types of palliative home care in cancer and non-cancer patients: A retrospective population-based study using claims data.

Germany administrative claims homecare services palliative care primary health care quality of health care retrospective studies terminal care

Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
06 2021
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 25 6 2021
Statut: ppublish

Résumé

Comparative effectiveness of different types of palliative homecare is sparsely researched internationally-despite its potential to inform necessary decisions in palliative care infrastructure development. In Germany, specialized palliative homecare delivered by multi-professional teams has increased in recent years and factors beyond medical need seem to drive its involvement and affect the application of primary palliative care, delivered by general practitioners who are supported by nursing services. To compare effectiveness of primary palliative care and specialized palliative homecare in reducing potentially aggressive interventions at the end-of-life in cancer and non-cancer. Retrospective population-based study with claims data from 95,962 deceased adults in Germany in 2016 using multivariable regression analyses. Patients having received primary palliative care or specialized palliative homecare (alone or in addition to primary palliative care), for at least 14 days before death, differentiating between cancer and non-cancer patients. Rates of potentially aggressive interventions in most indicators were higher in primary palliative care than in specialized palliative homecare ( Specialized palliative homecare is more strongly associated with reduction of potentially aggressive interventions than primary palliative care in the last days of life. Future research should identify elements of specialized palliative homecare applicable for more effective primary palliative care, too. German Clinical Trials Register (DRKS00014730).

Sections du résumé

BACKGROUND
Comparative effectiveness of different types of palliative homecare is sparsely researched internationally-despite its potential to inform necessary decisions in palliative care infrastructure development. In Germany, specialized palliative homecare delivered by multi-professional teams has increased in recent years and factors beyond medical need seem to drive its involvement and affect the application of primary palliative care, delivered by general practitioners who are supported by nursing services.
AIM
To compare effectiveness of primary palliative care and specialized palliative homecare in reducing potentially aggressive interventions at the end-of-life in cancer and non-cancer.
DESIGN
Retrospective population-based study with claims data from 95,962 deceased adults in Germany in 2016 using multivariable regression analyses.
SETTINGS/PARTICIPANTS
Patients having received primary palliative care or specialized palliative homecare (alone or in addition to primary palliative care), for at least 14 days before death, differentiating between cancer and non-cancer patients.
RESULTS
Rates of potentially aggressive interventions in most indicators were higher in primary palliative care than in specialized palliative homecare (
CONCLUSION
Specialized palliative homecare is more strongly associated with reduction of potentially aggressive interventions than primary palliative care in the last days of life. Future research should identify elements of specialized palliative homecare applicable for more effective primary palliative care, too. German Clinical Trials Register (DRKS00014730).

Identifiants

pubmed: 34092140
doi: 10.1177/02692163211013666
pmc: PMC8189010
doi:

Banques de données

DRKS
['DRKS00014730']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1158-1169

Références

J Palliat Med. 2019 Aug;22(8):966-969
pubmed: 30762462
BMC Palliat Care. 2019 Jan 26;18(1):12
pubmed: 30684958
J Palliat Med. 2016 Dec;19(12):1260-1266
pubmed: 27697009
Palliat Med. 2014 Jan;28(1):49-58
pubmed: 23695827
Palliat Support Care. 2020 Dec 09;:1-14
pubmed: 33295269
J Oncol Pract. 2015 May;11(3):e279-87
pubmed: 25922219
J Palliat Med. 2020 Mar;23(3):389-396
pubmed: 31644399
Support Care Cancer. 2018 Jul;26(7):2275-2283
pubmed: 29399722
Gesundheitswesen. 2016 Sep;78(S 01):e145-e160
pubmed: 27351686
Am Heart J. 2010 Jul;160(1):139-44
pubmed: 20598984
PLoS One. 2017 Feb 1;12(2):e0170168
pubmed: 28146566
Health Aff (Millwood). 2017 Jul 1;36(7):1234-1243
pubmed: 28679810
Ann Oncol. 2017 Apr 1;28(4):809-817
pubmed: 27993817
BMC Palliat Care. 2020 Aug 3;19(1):117
pubmed: 32746825
Palliat Med. 2018 Oct;32(9):1498-1508
pubmed: 30056802
Cochrane Database Syst Rev. 2016 Feb 18;2:CD009231
pubmed: 26887902
Am J Hosp Palliat Care. 2012 Sep;29(6):431-7
pubmed: 22057210
Palliat Med. 2018 Dec;32(10):1596-1604
pubmed: 30229696
J Pain Symptom Manage. 2014 Oct;48(4):660-77
pubmed: 24801658
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
BMJ. 2014 Jun 06;348:g3496
pubmed: 24906901
J Pain Symptom Manage. 2018 Oct;56(4):541-550.e6
pubmed: 29960021
Palliat Med. 2014 Dec;28(10):1167-96
pubmed: 24866758
BMJ Support Palliat Care. 2020 Dec 22;:
pubmed: 33355176
Cancer Med. 2020 Jan;9(2):530-540
pubmed: 31773922
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
J Pain Symptom Manage. 2011 Sep;42(3):331-41
pubmed: 21276704
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Palliat Med. 2018 Sep;32(8):1344-1352
pubmed: 29886795
JAMA. 2003 May 14;289(18):2387-92
pubmed: 12746362
J Clin Oncol. 2008 Dec 10;26(35):5671-8
pubmed: 19001333
BMC Palliat Care. 2018 Jan 4;17(1):12
pubmed: 29301524
Z Evid Fortbild Qual Gesundhwes. 2019 Dec;149:32-39
pubmed: 32059833
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD007760
pubmed: 23744578
Eur J Health Econ. 2013 Aug;14(4):629-38
pubmed: 22688440
N Engl J Med. 2013 Mar 28;368(13):1173-5
pubmed: 23465068
JAMA. 2016 Jan 19;315(3):272-83
pubmed: 26784775
Gesundheitswesen. 2016 Jul;78(7):431-7
pubmed: 25622209
BMJ Open. 2019 Jan 21;9(1):e025180
pubmed: 30670524

Auteurs

Markus Krause (M)

Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.

Bianka Ditscheid (B)

Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.

Thomas Lehmann (T)

Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Maximiliane Jansky (M)

Clinic for Palliative Medicine, University Medical Center Göttingen, Göttingen, Germany.

Ursula Marschall (U)

BARMER, Wuppertal, Germany.

Winfried Meißner (W)

Department of Palliative Care, Jena University Hospital, Jena, Germany.

Friedemann Nauck (F)

Clinic for Palliative Medicine, University Medical Center Göttingen, Göttingen, Germany.

Ulrich Wedding (U)

Department of Palliative Care, Jena University Hospital, Jena, Germany.

Antje Freytag (A)

Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH